69. Adler, S.P., et al., Guinea pig and human cytomegaloviruses do not share cross -reactive neutralizing epitopes. Journal of Medical Virology, 1995. 47(1): p . 48-51. 70. Adler, S.P., et al., Safety and immunogenicity of the Towne strain cytomegalovirus vaccine. Pediatric Infectious Disease Journal, 1998. 17(3): p. 200 -6. 71. Sachs, G.W., R.L. Simmons, and H.H. Balfour, Jr., Cytomegalovirus vaccine: persistence of humoral immunity following immunization of renal transplant candidates. Vaccine, 1984. 2(3): p. 215- 8. I-ATTAC Version: 20220204 60 72. Drulak, M.W., et al., Vaccination of seropositive subjects with CHIRON CMV gB subunit vaccine combined with MF59 adjuvant for production of CMV i mmune globulin. Viral Immunology, 2000. 13(1): p. 49 -56. 73. Ohizumi, Y., et al., Human cytomegalovirus neutralizing antibody response in Japanese children with bone marrow transplantation. Tohoku Journal of Experimental Medicine, 1994. 174 (1): p. 11 -7. 74. Hammond, D., CytoGam infusions at home. Journal of Intravenous Nursing, 1999. 22(6): p. 331 -5.